LGALS9 and glioblastoma: Taken together, these findings indicate that the accumulation of HGG-AM, regulatory and inhibitory immune cells, and exosomal LGALS9 in CSF may serve as markers for assessing the development and progression of GBM as well as a target for reversing its immunosuppressive TME status [64].